American Thinker
•Health
Health
70% Informative
Johann Hari assesses the benefits and risks of GLP-1 drugs such as Ozempic and Mounjaro that are used for weight loss and diabetes control.
Hari: Makers of these drugs acknowledge that there exists an increase in thyroid cancer, but since thyroid cancer is relatively uncommon, they insist that the benefits of weight loss outweigh the risk.
RFK Jr. has said that the administration is debating whether Medicare and Medicaid should cover some or all of the cost of the drugs for those who have tried other treatments.
Jeffrey Folks : There are other ways to control one’s weight and to prevent type-2 diabetes.
Processed food is not intended to keep us slim; it is designed to promote more consumption, resulting in weight gain.
Soon, a large percentage of our population will be relying on GLP-1 drugs.
VR Score
58
Informative language
48
Neutral language
60
Article tone
informal
Language
English
Language complexity
49
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
4
Source diversity
4
Affiliate links
no affiliate links